Top 10 Companies in the Medical Grade SEBS Market (2026): Market Leaders Powering Global Healthcare

In Business Insights
June 30, 2026

MARKET INSIGHTS

Global Medical Grade SEBS market size was valued at USD 182 million in 2025 and is projected to reach USD 305 million by 2034, exhibiting a CAGR of 6.7% during the forecast period.

Medical Grade SEBS (Styrene-Ethylene-Butylene-Styrene) is a high-performance thermoplastic elastomer recognized for its superior biocompatibility, chemical resistance, and excellent flexibility. This material is extensively utilized in critical healthcare applications, including IV infusion systems, catheter tubing, syringe components, and various medical device parts where patient safety and material durability are non-negotiable.

The market growth is propelled by rising global healthcare expenditure, which surpassed USD 8.5 trillion in 2024, and the increasing adoption of advanced medical devices. SEBS offers distinct advantages in medical settings because it maintains structural integrity through multiple sterilization cycles and performs reliably across a broad temperature range. Ongoing innovations in polymer science by leading manufacturers continue to expand its applications, particularly in drug delivery systems and minimally invasive surgical tools.

Medical Grade SEBS Market – View in Detailed Research Report


🔟 1. Kraton Corporation

Headquarters: Dallas, Texas, USA
Key Offering: Advanced hydrogenated styrenic block copolymers for medical tubing, IV bags, and syringe gaskets

Kraton has long been a leader in high-performance elastomers, with its SEBS portfolio engineered to meet stringent ISO 10993 and USP Class VI biocompatibility standards. The company’s extensive R&D network enables rapid development of new grades tailored for sterilization resilience and low extractables, positioning it as the preferred supplier for critical infusion and drug delivery devices.

Sustainability & Growth Initiatives:

  • Expansion of European production facilities to reduce carbon footprint
  • Investment in bio-based SEBS feedstock research
  • Partnerships with OEMs for customized low‑extractable formulations

9️⃣ 2. Kuraray Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Septon™ polymer series for surgical instruments, implantable devices, and catheter tubing

Kuraray’s Septon® line delivers exceptional mechanical strength and clarity while maintaining biocompatibility. Its patented hydrogenation process reduces residual styrene, enhancing safety for long‑term implants and high‑temperature sterilization cycles.

Sustainability & Growth Initiatives:

  • ISO 14001 certified manufacturing plants
  • Development of recyclable SEBS grades for single‑use medical devices
  • Collaboration with global OEMs to integrate eco‑friendly packaging solutions

8️⃣ 3. TSRC Corporation

Headquarters: Taipei, Taiwan
Key Offering: GMP‑certified SEBS for medical tubing, IV bags, and syringe components

TSRC’s focus on quality‑centric manufacturing has positioned it as a trusted supplier for hospitals and medical device manufacturers seeking cost‑effective, high‑grade elastomers. Its recent investment in GMP‑certified lines enhances compliance with FDA and EMA requirements.

Sustainability & Growth Initiatives:

  • Implementation of closed‑loop water recycling in extrusion lines
  • Partnerships with regional distributors to reduce logistics emissions
  • Development of high‑clarity SEBS for diagnostic instruments

7️⃣ 4. Sinopec

Headquarters: Beijing, China
Key Offering: Large‑scale production of medical‑grade SEBS for IV bags, catheter tubing, and drug delivery systems

Sinopec leverages its petrochemical infrastructure to supply high‑volume, cost‑competitive SEBS grades while maintaining rigorous biocompatibility testing. The company is expanding its R&D focus on antibacterial SEBS formulations for hospital use.

Sustainability & Growth Initiatives:

  • Adoption of renewable energy in production facilities
  • Investment in bio‑based monomer synthesis
  • Collaboration with Chinese medical device OEMs for regional market penetration

6️⃣ 5. Asahi Kasei Corporation

Headquarters: Tokyo, Japan
Key Offering: SEBS for medical tubing, syringe gaskets, and implantable components

Asahi Kasei’s SEBS portfolio emphasizes low extractables and high sterilization resistance, making it ideal for long‑term implantable devices and high‑frequency disposable medical devices.

Sustainability & Growth Initiatives:

  • Development of recyclable SEBS for single‑use medical devices
  • Partnerships with global OEMs to integrate circular economy practices
  • Investment in advanced extrusion technologies for ultra‑clear grades

5️⃣ 6. LCY Group

Headquarters: Taipei, Taiwan
Key Offering: Medical‑grade SEBS for IV bags, catheter tubing, and syringe gaskets

LCY Group focuses on cost‑effective production while ensuring compliance with ISO 10993. Its SEBS is widely used in single‑use disposable devices across hospitals in Asia‑Pacific.

Sustainability & Growth Initiatives:

  • Implementation of waste‑to‑energy programs in manufacturing sites
  • Development of low‑cost, high‑clarity SEBS for diagnostic tools
  • Strategic alliances with regional distributors for market expansion

4️⃣ 7. JSR Corporation

Headquarters: Tokyo, Japan
Key Offering: SEBS for medical tubing, IV bags, and drug delivery devices

JSR’s SEBS grades are engineered for high flexibility and chemical resistance, meeting the demanding requirements of infusion therapy and minimally invasive surgical tools.

Sustainability & Growth Initiatives:

  • Use of renewable feedstocks in polymer synthesis
  • Partnerships with OEMs for recyclable packaging solutions
  • Investment in R&D for antibacterial SEBS formulations

3️⃣ 8. Versalis S.p.A.

Headquarters: Milan, Italy
Key Offering: Medical‑grade SEBS for IV bags, catheter tubing, and syringe components

Versalis’s SEBS portfolio focuses on high‑clarity grades suitable for diagnostic instruments and drug delivery systems, with strong emphasis on biocompatibility and sterilization durability.

Sustainability & Growth Initiatives:

  • Implementation of ISO 14001 environmental management systems
  • Development of recyclable SEBS for single‑use medical devices
  • Collaboration with European OEMs to enhance circular economy practices

2️⃣ 9. Chi Mei Corporation

Headquarters: Taichung, Taiwan
Key Offering: SEBS for IV bags, catheter tubing, and syringe gaskets

Chi Mei’s SEBS is known for its excellent mechanical properties and low extractables, making it a preferred choice for disposable infusion systems and drug delivery devices.

Sustainability & Growth Initiatives:

  • Adoption of energy‑efficient extrusion lines
  • Investment in bio‑based monomer research
  • Strategic partnerships with regional OEMs for market expansion

1️⃣ 10. Lubrizol Corporation

Headquarters: St. Louis, Missouri, USA
Key Offering: Advanced SEBS formulations for medical tubing, IV bags, and implantable devices

Lubrizol’s recent entry into the medical‑grade polymer space is driven by its expertise in high‑performance elastomers and a focus on antibacterial and low‑extractable SEBS grades for hospital applications.

Sustainability & Growth Initiatives:

  • Investment in renewable energy for manufacturing facilities
  • Development of recyclable SEBS grades for single‑use medical devices
  • Partnerships with OEMs to deliver customized, compliant formulations

Download FREE Sample Report: Medical Grade SEBS Market – View in Detailed Research Report

Get Full Report Here: Medical Grade SEBS Market – View in Detailed Research Report


🌍 Outlook: The Future of Medical Grade SEBS Is Growing

The medical‑grade SEBS market is poised for robust expansion as healthcare systems worldwide accelerate adoption of high‑performance, biocompatible materials. Key drivers include increasing chronic disease prevalence, aging populations, and the shift toward single‑use disposable devices to reduce infection risks. Regulatory momentum—particularly FDA and EMA biocompatibility standards—continues to shape product development, while sustainability imperatives push manufacturers toward recyclable and bio‑based SEBS solutions.

📈 Key Trends Shaping the Market:

  • Rapid growth in minimally invasive surgical tools and drug delivery systems
  • Expansion of single‑use disposable device market driven by infection control protocols
  • Accelerated R&D in antibacterial and low‑extractable SEBS formulations
  • Strategic collaborations between elastomer suppliers and medical device OEMs
  • Increased focus on circular economy and recyclable medical polymers